Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2005
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2002057256A9 Piperazinylcarbonylquinolines and -isoquinolines
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272800 NK1 antagonists
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2.
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2565065A1 Therapeutic compounds: pyridine as scaffold
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602373A1 Ocular hypotensive agent
12/07/2005EP1601670A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
12/07/2005EP1601668A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/07/2005EP1601665A2 Urea derivatives
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1527053B1 Process for preparing rizatriptan
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1450800A4 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1175410B1 Pesticidal triazine derivatives
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705657A Azole derivatives as antifungal agents
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1705646A Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/01/2005WO2005113605A1 Cross-linked antibodies
12/01/2005WO2005113549A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005WO2005113546A1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
12/01/2005WO2005113545A1 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors
12/01/2005WO2005113538A1 2-substituted pyrimidines and their use as pesticides
12/01/2005WO2005113535A2 Pyrazinylmethyl lactam derivatives
12/01/2005WO2005113518A1 Process for preparing irbesartan
12/01/2005WO2005113516A1 Uracil-type gonadotropin-releasing hormone receptor antagonists and methods related thereto
12/01/2005WO2005113515A1 Pyrimidines for use as plk inhibitors
12/01/2005WO2005113504A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005WO2005113501A1 Neurogenic pain control agent composition
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005112932A2 Raf modulators and methods of use
12/01/2005WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication
12/01/2005WO2005082862A3 Benzimidazolyl derivatives as kinase inhibitors
12/01/2005WO2005082848A3 Method for preparing pyrrolidine oximes
12/01/2005WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto
12/01/2005WO2005019167A3 Melanin concentrating hormone receptor antagonist
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267192 Growing strain NPS012745 in a culture and recovering bis- indole pyrroles from it
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267184 3-Aminocarbonyl substituted benzoylpyrazolones
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267150 Treating Alzheimer's disease with substituted urea or thiourea-alkylamidolactone compound
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005CA2567483A1 Pyrazinylmethyl lactam derivatives
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2566937A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2566444A1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
12/01/2005CA2565200A1 Raf modulators and methods of use
12/01/2005CA2564076A1 Chemical linkers and conjugates thereof
12/01/2005CA2563968A1 Neurogenic pain control agent composition
12/01/2005CA2562701A1 Cross-linked antibodies
12/01/2005CA2562315A1 2-substituted pyrimidines and their use as pesticides
12/01/2005CA2562027A1 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors
11/2005
11/30/2005EP1599474A2 Alternative heterocycles for dna recognition
11/30/2005EP1599469A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 626